Abstract
The growth of a CBA mammary adenocarcinoma has been studied following transplantation to syngeneic and allogeneic recipients, with particular reference to the susceptibilities of the primary and secondary responses elicited by the tumour allografts, to impairment by whole-body X-irradiation and by treatment with rabbit-anti-mouse lymphocyte serum. In syngeneic recipients, the diameter of tumour implants increases linearly with time and there is no difference in the growth curves in females and in males. Later tumour generations grow faster than earlier generations. In allogeneic recipients, there is a relationship between the tumour diameter on day 21 (T) and the dose of X-irradiation (D) administered before implantation:
T = 0.028 D - 9.17
for early tumour generations (SMT4) but this is obscured for later generations (SMT21). The primary response to tumour allografts was radiosensitive whereas the secondary response was radioresistant. This radioresistance of the secondary response persisted for at least 5 months after primary sensitization. Unlike whole-body X-irradiation, treatment with rabbit-anti-mouse lymphocyte serum suppresses both the primary and secondary responses to tumour allografts. The possibility is considered that after exposure to antigenic stimulation, an immunologically reactive cell population is formed which is radioresistant but sensitive to ALS, unlike the precursor cells from which this population is derived, which are radiosensitive and sensitive to ALS.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brent L., Medawar P. Quantitative studies on tissue transplantation immunity. 8. The effects of irradiation. Proc R Soc Lond B Biol Sci. 1966 Oct 11;165(1001):413–423. doi: 10.1098/rspb.1966.0074. [DOI] [PubMed] [Google Scholar]
- Deodhar S. D., Crile G., Jr Enhancement of metastases by antilymphocyte serum in allogeneic murine tumor system. Cancer Res. 1969 Apr;29(4):776–779. [PubMed] [Google Scholar]
- Deodhar S. D., Crile G., Jr, Schofield P. F. Immunosuppression in allogeneic murine tumour system. A model for the study of antilymphocyte serum. Lancet. 1968 Jan 27;1(7535):168–170. doi: 10.1016/s0140-6736(68)92562-2. [DOI] [PubMed] [Google Scholar]
- Nettesheim P., Williams M. L. Regenerative potential of immunocompetent cells. II. Factors influencing recovery of secondary antibody-forming potential from x-irradiation. J Immunol. 1968 Apr;100(4):760–770. [PubMed] [Google Scholar]
- Nossal G. J. The mechanism of action of antigen. Australas Ann Med. 1965 Nov;14(4):321–328. doi: 10.1111/imj.1965.14.4.321. [DOI] [PubMed] [Google Scholar]
- Rosenau W., Moon H. D. Suppression of the immune response to antigenic tumors in isogenic mice by whole-body irradiation. Cancer Res. 1967 Nov;27(11):1973–1981. [PubMed] [Google Scholar]
- Starzl T. E., Marchioro T. L., Porter K. A., Iwasaki Y., Cerilli G. J. The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet. 1967 Feb;124(2):301–308. [PMC free article] [PubMed] [Google Scholar]
- TYAN M. L., COLE L. J. DIFFERENTIAL RADIOSENSITIVITY OF FIRST AND SECOND-SET RESPONSES TO ALLOGENEIC AND XENOGENEIC SKIN GRAFTS IN SUBLETHALLY IRRADIATED MICE. Transplantation. 1963 Oct;1:546–551. [PubMed] [Google Scholar]
- WOODRUFF M. F., SYMES M. O. The use of immunologically competent cells in the treatment of cancer: experiments with a transplantable mouse tumour. Br J Cancer. 1962 Dec;16:707–715. doi: 10.1038/bjc.1962.82. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wexler H., Orme S. K., Ketcham A. S. Biological behavior through successive transplant generations of transplantable tumors derived originally from primary chemically induced and spontaneous sources in mice. J Natl Cancer Inst. 1968 Mar;40(3):513–523. [PubMed] [Google Scholar]